Ensysce Biosciences
ENSC----
Ensysce Biosciences (ENSC)
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ensysce Biosciences Analyst Rating
View MoreForecast & Rating
Jul 14, 2026Price forecast
$16.455934.48%
Forecast & Rating-
0analysts
News
- PUBT · Jul 15 at 03:16 PM
Ensysce Biosciences COO Jeffrey Millard resigns
- Price Alert · Jul 15 at 04:12 AM
Pre-market hot trades in US stocks: Ensysce Biosciences pre-market down 9.37%; U-BX Tech pre-market down 9.33%
- benzinga_article · Jul 14 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- PUBT · Jun 26 at 07:04 AM
Ensysce enrolls first patient in final phase of PF614-MPAR-102 overdose-protection trial
- Price Alert · May 19 at 04:42 AM
Pre-market hot trades in US stocks: Star Fashion Culture pre-market down 8.75%; Ensysce Biosciences pre-market down 8.52%
- Earnings Watch · May 15 at 11:10 PM
Ensysce Biosciences | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 961 K
